Ulcerative colitis

Clinical trials are how new treatments become available, so participation and awareness can directly affect treatment options for people with Crohn’s disease and ulcerative colitis. The article also highlights that...

Skin disease (hidradenitis suppurativa) may be more common in people with IBD—particularly Crohn disease—and could be linked with more severe intestinal complications. Awareness can prompt coordinated care between...

The review brings together evidence that genetics, immune responses, the gut microbiome, and environmental triggers interact to cause Crohn's disease and ulcerative colitis.

After a Crohn’s or UC flare you may tolerate less fiber and need easy-to-digest foods and extra protein to support recovery. This article gives practical, food-based suggestions to help with nutrient intake while your...

Fatigue is common in people with Crohn’s disease and ulcerative colitis and can persist even when standard measures say the disease is in remission. This study suggests stricter definitions of remission don’t necessarily...

This notes a new oral investigational drug (Amelenodor/NX-13) in Phase I for Crohn’s and ulcerative colitis and highlights industry predictions about its chances of advancing. People with IBD may want to know about...

Seeing well-known people talk about IBD or IBS can reduce stigma and show that these conditions affect many kinds of people, including athletes and performers. The article may help patients feel less alone and point to...